-
Measuring perceived-health status in Parkinson’s Disease – the role of London Handicap Scale
-
Measuring progression of nigrostriatal degeneration in Parkinson’s disease using 18F-AV-133 vesicular monoamine transporter type-2 (VMAT2) PET
-
Mechanism-based classification in PD cohorts
-
Mechanisms underlying therapeutic group singing in persons with Parkinson’s disease
-
Medical and Device-Guided Therapies and Deep Brain Stimulation in Parkinson’s disease: Experience of a Tertiary Centre from Turkey
-
Medical evaluation as gold standard to control iPrognosis application derived data for early Parkinson’s disease detection
-
Medical management after subthalamic nucleus deep brain stimulation in patients with Parkinson’s Disease
-
Medical management of primary hemifacial spasm
-
Memantine and 3D gait analysis in patient with Parkinson’s disease: an observer-blind randomized clinical trial
-
Memantine induced dyskinesia in Alzheimer’s disease
- « Previous Page
- 1
- …
- 121
- 122
- 123
- 124
- 125
- …
- 217
- Next Page »